APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transient Receptor Potential Cation Channel Subfamily V Member 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Growth and Trends Forecast to 2032

Report ID 174042740119 December 2025114 pages

Choose your research edition.

Industry ResearchTransient Receptor Potential Cation Channel Subfamily V Member 1 Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Transient Receptor Potential Cation Channel Subfamily V Member 1 market include Amgen Inc, Vitality Biopharma Inc, Toray Industries Inc, Sylentis SAU, Pila Pharma AB, Neurim Pharmaceuticals Ltd, Medifron DBT Co Ltd, Kyowa Hakko Kirin Co Ltd and Grunenthal GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transient Receptor Potential Cation Channel Subfamily V Member 1 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transient Receptor Potential Cation Channel Subfamily V Member 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Company

Amgen Inc

Vitality Biopharma Inc

Toray Industries Inc

Sylentis SAU

Pila Pharma AB

Neurim Pharmaceuticals Ltd

Medifron DBT Co Ltd

Kyowa Hakko Kirin Co Ltd

Grunenthal GmbH

Flex Pharma Inc

DoNatur GmbH

Daewoong Pharmaceutical Co Ltd

Centrexion Therapeutics Corp

BCN Peptides SA

Amorepacific Corp

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type

DD-04107

CMX-020

CA-016

Others

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application

Abdominal Pain

Muscle Spasm

Immunology

Pruritus

Ophthalmology

Others

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transient Receptor Potential Cation Channel Subfamily V Member 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transient Receptor Potential Cation Channel Subfamily V Member 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2021-2026) Table 4. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2027-2032) Table 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Type (2021-2026) Table 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share Forecasted by Type (2027-2032) Table 11. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application (2021-2026) Table 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share Forecasted by Application (2027-2032) Table 26. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends Table 37. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers Table 38. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges Table 39. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Restraints Table 40. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Company (2021-2026) Table 42. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Company Headquarters & Area Served Table 44. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company, Product Type & Application Table 45. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Amgen Inc Company Information Table 49. Amgen Inc Business Overview Table 50. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 52. Amgen Inc Recent Development Table 53. Vitality Biopharma Inc Company Information Table 54. Vitality Biopharma Inc Business Overview Table 55. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 57. Vitality Biopharma Inc Recent Development Table 58. Toray Industries Inc Company Information Table 59. Toray Industries Inc Business Overview Table 60. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 62. Toray Industries Inc Recent Development Table 63. Sylentis SAU Company Information Table 64. Sylentis SAU Business Overview Table 65. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 67. Sylentis SAU Recent Development Table 68. Pila Pharma AB Company Information Table 69. Pila Pharma AB Business Overview Table 70. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 72. Pila Pharma AB Recent Development Table 73. Neurim Pharmaceuticals Ltd Company Information Table 74. Neurim Pharmaceuticals Ltd Business Overview Table 75. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 77. Neurim Pharmaceuticals Ltd Recent Development Table 78. Medifron DBT Co Ltd Company Information Table 79. Medifron DBT Co Ltd Business Overview Table 80. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 82. Medifron DBT Co Ltd Recent Development Table 83. Kyowa Hakko Kirin Co Ltd Company Information Table 84. Kyowa Hakko Kirin Co Ltd Business Overview Table 85. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 87. Kyowa Hakko Kirin Co Ltd Recent Development Table 88. Grunenthal GmbH Company Information Table 89. Grunenthal GmbH Business Overview Table 90. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 92. Grunenthal GmbH Recent Development Table 93. Flex Pharma Inc Company Information Table 94. Flex Pharma Inc Business Overview Table 95. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 97. Flex Pharma Inc Recent Development Table 98. DoNatur GmbH Company Information Table 99. DoNatur GmbH Business Overview Table 100. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 102. DoNatur GmbH Recent Development Table 103. Daewoong Pharmaceutical Co Ltd Company Information Table 104. Daewoong Pharmaceutical Co Ltd Business Overview Table 105. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 107. Daewoong Pharmaceutical Co Ltd Recent Development Table 108. Centrexion Therapeutics Corp Company Information Table 109. Centrexion Therapeutics Corp Business Overview Table 110. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 112. Centrexion Therapeutics Corp Recent Development Table 113. BCN Peptides SA Company Information Table 114. BCN Peptides SA Business Overview Table 115. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 117. BCN Peptides SA Recent Development Table 118. Amorepacific Corp Company Information Table 119. Amorepacific Corp Business Overview Table 120. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 122. Amorepacific Corp Recent Development Table 123. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2026) Table 126. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share Forecast by Country (2027-2032) Table 128. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2026) Table 131. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2026) Table 136. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share Forecast by Country (2027-2032) Table 138. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2026) Table 141. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2026) Table 146. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Image Figure 3. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region: 2025 VS 2032 Figure 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2021-2032) Figure 7. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. DD-04107 Image Figure 13. Global DD-04107 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. CMX-020 Image Figure 15. Global CMX-020 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. CA-016 Image Figure 17. Global CA-016 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type 2025 VS 2032 Figure 22. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Type (2021-2032) Figure 23. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Type (2021-2032) Figure 25. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Type (2021-2032) Figure 27. Abdominal Pain Image Figure 28. Global Abdominal Pain Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Muscle Spasm Image Figure 30. Global Muscle Spasm Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Immunology Image Figure 32. Global Immunology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Pruritus Image Figure 34. Global Pruritus Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Ophthalmology Image Figure 36. Global Ophthalmology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application 2025 VS 2032 Figure 41. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application (2021-2032) Figure 42. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application (2021-2032) Figure 44. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 51. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 54. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 57. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 60. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • DD-04107
  • CMX-020
  • CA-016
  • Others
Applications
  • Abdominal Pain
  • Muscle Spasm
  • Immunology
  • Pruritus
  • Ophthalmology
  • Others
Companies covered
  • Amgen Inc
  • Vitality Biopharma Inc
  • Toray Industries Inc
  • Sylentis SAU
  • Pila Pharma AB
  • Neurim Pharmaceuticals Ltd
  • Medifron DBT Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Grunenthal GmbH
  • Flex Pharma Inc
  • DoNatur GmbH
  • Daewoong Pharmaceutical Co Ltd
  • Centrexion Therapeutics Corp
  • BCN Peptides SA
  • Amorepacific Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2032)
  5. 1.4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2026)
  6. 1.4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2027-2032)
  7. 1.5 Key Regions Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  8. 1.5.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2021-2032)
2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 DD-04107
  3. 2.1.2 CMX-020
  4. 2.1.3 CA-016
  5. 2.1.4 Others
  6. 2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
  7. 2.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions
  11. 2.3.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Type (2021-2026)
3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Abdominal Pain
  3. 3.1.2 Muscle Spasm
  4. 3.1.3 Immunology
  5. 3.1.4 Pruritus
  6. 3.1.5 Ophthalmology
  7. 3.1.6 Others
  8. 3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
  9. 3.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions
  13. 3.3.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
  2. 4.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers
  3. 4.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges
  4. 4.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2021-2026)
  2. 5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Company Headquarters & Area Served
  4. 5.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company, Product Type & Application
  5. 5.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Transient Receptor Potential Cation Channel Subfamily V Member 1 Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Amgen Inc
  2. 6.1.1 Amgen Inc Company Information
  3. 6.1.2 Amgen Inc Business Overview
  4. 6.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  6. 6.1.5 Amgen Inc Recent Developments
  7. 6.2 Vitality Biopharma Inc
  8. 6.2.1 Vitality Biopharma Inc Company Information
  9. 6.2.2 Vitality Biopharma Inc Business Overview
  10. 6.2.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  12. 6.2.5 Vitality Biopharma Inc Recent Developments
  13. 6.3 Toray Industries Inc
  14. 6.3.1 Toray Industries Inc Company Information
  15. 6.3.2 Toray Industries Inc Business Overview
  16. 6.3.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  18. 6.3.5 Toray Industries Inc Recent Developments
  19. 6.4 Sylentis SAU
  20. 6.4.1 Sylentis SAU Company Information
  21. 6.4.2 Sylentis SAU Business Overview
  22. 6.4.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  24. 6.4.5 Sylentis SAU Recent Developments
  25. 6.5 Pila Pharma AB
  26. 6.5.1 Pila Pharma AB Company Information
  27. 6.5.2 Pila Pharma AB Business Overview
  28. 6.5.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  30. 6.5.5 Pila Pharma AB Recent Developments
  31. 6.6 Neurim Pharmaceuticals Ltd
  32. 6.6.1 Neurim Pharmaceuticals Ltd Company Information
  33. 6.6.2 Neurim Pharmaceuticals Ltd Business Overview
  34. 6.6.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  36. 6.6.5 Neurim Pharmaceuticals Ltd Recent Developments
  37. 6.7 Medifron DBT Co Ltd
  38. 6.7.1 Medifron DBT Co Ltd Company Information
  39. 6.7.2 Medifron DBT Co Ltd Business Overview
  40. 6.7.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  42. 6.7.5 Medifron DBT Co Ltd Recent Developments
  43. 6.8 Kyowa Hakko Kirin Co Ltd
  44. 6.8.1 Kyowa Hakko Kirin Co Ltd Company Information
  45. 6.8.2 Kyowa Hakko Kirin Co Ltd Business Overview
  46. 6.8.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  48. 6.8.5 Kyowa Hakko Kirin Co Ltd Recent Developments
  49. 6.9 Grunenthal GmbH
  50. 6.9.1 Grunenthal GmbH Company Information
  51. 6.9.2 Grunenthal GmbH Business Overview
  52. 6.9.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  54. 6.9.5 Grunenthal GmbH Recent Developments
  55. 6.10 Flex Pharma Inc
  56. 6.10.1 Flex Pharma Inc Company Information
  57. 6.10.2 Flex Pharma Inc Business Overview
  58. 6.10.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  60. 6.10.5 Flex Pharma Inc Recent Developments
  61. 6.11 DoNatur GmbH
  62. 6.11.1 DoNatur GmbH Company Information
  63. 6.11.2 DoNatur GmbH Business Overview
  64. 6.11.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  66. 6.11.5 DoNatur GmbH Recent Developments
  67. 6.12 Daewoong Pharmaceutical Co Ltd
  68. 6.12.1 Daewoong Pharmaceutical Co Ltd Company Information
  69. 6.12.2 Daewoong Pharmaceutical Co Ltd Business Overview
  70. 6.12.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  72. 6.12.5 Daewoong Pharmaceutical Co Ltd Recent Developments
  73. 6.13 Centrexion Therapeutics Corp
  74. 6.13.1 Centrexion Therapeutics Corp Company Information
  75. 6.13.2 Centrexion Therapeutics Corp Business Overview
  76. 6.13.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  78. 6.13.5 Centrexion Therapeutics Corp Recent Developments
  79. 6.14 BCN Peptides SA
  80. 6.14.1 BCN Peptides SA Company Information
  81. 6.14.2 BCN Peptides SA Business Overview
  82. 6.14.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  84. 6.14.5 BCN Peptides SA Recent Developments
  85. 6.15 Amorepacific Corp
  86. 6.15.1 Amorepacific Corp Company Information
  87. 6.15.2 Amorepacific Corp Business Overview
  88. 6.15.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  90. 6.15.5 Amorepacific Corp Recent Developments
7 North America
  1. 7.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  3. 7.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  3. 8.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  3. 10.3 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst